APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tumor Target Capture Platform

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Tumor Target Capture Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

15 April 2026190 pages

Choose your research edition.

Industry ResearchTumor Target Capture Platform Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Tumor Target Capture Platform Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Tumor Target Capture Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tumor Target Capture Platform Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Tumor Target Capture Platform Market Analysis and Forecast 2026-2032251 pages · $4,950 USD

Market perspective

The global Tumor Target Capture Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Tumor Target Capture Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tumor Target Capture Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tumor Target Capture Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Tumor Target Capture Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tumor Target Capture Platform include Roche, Guardant Health, Illumina, Bio-Rad, Menarini Silicon Biosystems, GRAIL, Freenome, Angle and Exosome Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Tumor Target Capture Platform market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tumor Target Capture Platform and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tumor Target Capture Platform revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Tumor Target Capture Platform market size, projected growth trends, production technologies, key applications, and end-use industries.

Tumor Target Capture Platform Segment by Company

Roche

Guardant Health

Illumina

Bio-Rad

Menarini Silicon Biosystems

GRAIL

Freenome

Angle

Exosome Diagnostics

Nanostring

Cell Microsystems

Vortex Biosciences

MagArray

Qiagen

Adaptive Biotechnologies

Mission Bio

Singleron

BGI

Amoy Diagnostics

GenoSaber

Annoroad

Genecast

Precision Scientific

Tumor Target Capture Platform Segment by Type

Immunoaffinity Capture Platform

Aptamer Capture Platform

Physical Separation Platform

Tumor Target Capture Platform Segment by Application

Clinical Diagnostics Industry

Laboratory Industry

Research and Higher Education Industry

Others

Tumor Target Capture Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Target Capture Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tumor Target Capture Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Target Capture Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Tumor Target Capture Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tumor Target Capture Platform industry.

Chapter 3: Detailed analysis of Tumor Target Capture Platform companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tumor Target Capture Platformrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tumor Target Capture Platform Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Immunoaffinity Capture Platform Table 3. Key Players of Aptamer Capture Platform Table 4. Key Players of Physical Separation Platform Table 4. Global Tumor Target Capture Platform Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Clinical Diagnostics Industry Table 6. Key Players of Laboratory Industry Table 7. Key Players of Research and Higher Education Industry Table 8. Key Players of Others Table 9. Global Tumor Target Capture Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Tumor Target Capture Platform Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Tumor Target Capture Platform Market Share by Region (2021-2026) Table 12. Global Tumor Target Capture Platform Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Tumor Target Capture Platform Market Share by Region (2027-2032) Table 14. Tumor Target Capture Platform Industry Trends Table 15. Tumor Target Capture Platform Industry Drivers Table 16. Tumor Target Capture Platform Industry Opportunities and Challenges Table 17. Tumor Target Capture Platform Industry Restraints Table 18. Global Tumor Target Capture Platform Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Tumor Target Capture Platform Revenue Market Share by Company (2021-2026) Table 20. Global Tumor Target Capture Platform Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Tumor Target Capture Platform Key Company Head Office and Area Served Table 22. Global Tumor Target Capture Platform Company, Product Type & Application Table 23. Global Tumor Target Capture Platform Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Tumor Target Capture Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Tumor Target Capture Platform Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Tumor Target Capture Platform Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Tumor Target Capture Platform Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Tumor Target Capture Platform Revenue Market Share by Type (2021-2026) Table 30. Global Tumor Target Capture Platform Revenue Market Share by Type (2027-2032) Table 31. Global Tumor Target Capture Platform Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Tumor Target Capture Platform Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Tumor Target Capture Platform Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Tumor Target Capture Platform Revenue Market Share by Application (2021-2026) Table 35. Global Tumor Target Capture Platform Revenue Market Share by Application (2027-2032) Table 36. Roche Company Information Table 37. Roche Business Overview Table 38. Roche Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Roche Tumor Target Capture Platform Product Portfolio Table 40. Roche Recent Development Table 41. Guardant Health Company Information Table 42. Guardant Health Business Overview Table 43. Guardant Health Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Guardant Health Tumor Target Capture Platform Product Portfolio Table 45. Guardant Health Recent Development Table 46. Illumina Company Information Table 47. Illumina Business Overview Table 48. Illumina Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Illumina Tumor Target Capture Platform Product Portfolio Table 50. Illumina Recent Development Table 51. Bio-Rad Company Information Table 52. Bio-Rad Business Overview Table 53. Bio-Rad Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Bio-Rad Tumor Target Capture Platform Product Portfolio Table 55. Bio-Rad Recent Development Table 56. Menarini Silicon Biosystems Company Information Table 57. Menarini Silicon Biosystems Business Overview Table 58. Menarini Silicon Biosystems Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Menarini Silicon Biosystems Tumor Target Capture Platform Product Portfolio Table 60. Menarini Silicon Biosystems Recent Development Table 61. GRAIL Company Information Table 62. GRAIL Business Overview Table 63. GRAIL Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. GRAIL Tumor Target Capture Platform Product Portfolio Table 65. GRAIL Recent Development Table 66. Freenome Company Information Table 67. Freenome Business Overview Table 68. Freenome Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Freenome Tumor Target Capture Platform Product Portfolio Table 70. Freenome Recent Development Table 71. Angle Company Information Table 72. Angle Business Overview Table 73. Angle Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Angle Tumor Target Capture Platform Product Portfolio Table 75. Angle Recent Development Table 76. Exosome Diagnostics Company Information Table 77. Exosome Diagnostics Business Overview Table 78. Exosome Diagnostics Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Exosome Diagnostics Tumor Target Capture Platform Product Portfolio Table 80. Exosome Diagnostics Recent Development Table 81. Nanostring Company Information Table 82. Nanostring Business Overview Table 83. Nanostring Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Nanostring Tumor Target Capture Platform Product Portfolio Table 85. Nanostring Recent Development Table 86. Cell Microsystems Company Information Table 87. Cell Microsystems Business Overview Table 88. Cell Microsystems Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Cell Microsystems Tumor Target Capture Platform Product Portfolio Table 90. Cell Microsystems Recent Development Table 91. Vortex Biosciences Company Information Table 92. Vortex Biosciences Business Overview Table 93. Vortex Biosciences Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Vortex Biosciences Tumor Target Capture Platform Product Portfolio Table 95. Vortex Biosciences Recent Development Table 96. MagArray Company Information Table 97. MagArray Business Overview Table 98. MagArray Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. MagArray Tumor Target Capture Platform Product Portfolio Table 100. MagArray Recent Development Table 101. Qiagen Company Information Table 102. Qiagen Business Overview Table 103. Qiagen Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Qiagen Tumor Target Capture Platform Product Portfolio Table 105. Qiagen Recent Development Table 106. Adaptive Biotechnologies Company Information Table 107. Adaptive Biotechnologies Business Overview Table 108. Adaptive Biotechnologies Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Adaptive Biotechnologies Tumor Target Capture Platform Product Portfolio Table 110. Adaptive Biotechnologies Recent Development Table 111. Mission Bio Company Information Table 112. Mission Bio Business Overview Table 113. Mission Bio Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Mission Bio Tumor Target Capture Platform Product Portfolio Table 115. Mission Bio Recent Development Table 116. Singleron Company Information Table 117. Singleron Business Overview Table 118. Singleron Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Singleron Tumor Target Capture Platform Product Portfolio Table 120. Singleron Recent Development Table 121. BGI Company Information Table 122. BGI Business Overview Table 123. BGI Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. BGI Tumor Target Capture Platform Product Portfolio Table 125. BGI Recent Development Table 126. Amoy Diagnostics Company Information Table 127. Amoy Diagnostics Business Overview Table 128. Amoy Diagnostics Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 129. Amoy Diagnostics Tumor Target Capture Platform Product Portfolio Table 130. Amoy Diagnostics Recent Development Table 131. GenoSaber Company Information Table 132. GenoSaber Business Overview Table 133. GenoSaber Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 134. GenoSaber Tumor Target Capture Platform Product Portfolio Table 135. GenoSaber Recent Development Table 136. Annoroad Company Information Table 137. Annoroad Business Overview Table 138. Annoroad Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 139. Annoroad Tumor Target Capture Platform Product Portfolio Table 140. Annoroad Recent Development Table 141. Genecast Company Information Table 142. Genecast Business Overview Table 143. Genecast Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 144. Genecast Tumor Target Capture Platform Product Portfolio Table 145. Genecast Recent Development Table 146. Precision Scientific Company Information Table 147. Precision Scientific Business Overview Table 148. Precision Scientific Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 149. Precision Scientific Tumor Target Capture Platform Product Portfolio Table 150. Precision Scientific Recent Development Table 151. North America Tumor Target Capture Platform Market Size by Type (2021-2026) & (US$ Million) Table 152. North America Tumor Target Capture Platform Market Size by Type (2027-2032) & (US$ Million) Table 153. North America Tumor Target Capture Platform Market Size by Application (2021-2026) & (US$ Million) Table 154. North America Tumor Target Capture Platform Market Size by Application (2027-2032) & (US$ Million) Table 155. North America Tumor Target Capture Platform Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. North America Tumor Target Capture Platform Market Size by Country (2021-2026) Table 157. North America Tumor Target Capture Platform Market Size by Country (2027-2032) Table 158. Europe Tumor Target Capture Platform Market Size by Type (2021-2026) & (US$ Million) Table 159. Europe Tumor Target Capture Platform Market Size by Type (2027-2032) & (US$ Million) Table 160. Europe Tumor Target Capture Platform Market Size by Application (2021-2026) & (US$ Million) Table 161. Europe Tumor Target Capture Platform Market Size by Application (2027-2032) & (US$ Million) Table 162. Europe Tumor Target Capture Platform Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Europe Tumor Target Capture Platform Market Size by Country (2021-2026) Table 164. Europe Tumor Target Capture Platform Market Size by Country (2027-2032) Table 165. China Tumor Target Capture Platform Market Size by Type (2021-2026) & (US$ Million) Table 166. China Tumor Target Capture Platform Market Size by Type (2027-2032) & (US$ Million) Table 167. China Tumor Target Capture Platform Market Size by Application (2021-2026) & (US$ Million) Table 168. China Tumor Target Capture Platform Market Size by Application (2027-2032) & (US$ Million) Table 169. Asia Tumor Target Capture Platform Market Size by Type (2021-2026) & (US$ Million) Table 170. Asia Tumor Target Capture Platform Market Size by Type (2027-2032) & (US$ Million) Table 171. Asia Tumor Target Capture Platform Market Size by Application (2021-2026) & (US$ Million) Table 172. Asia Tumor Target Capture Platform Market Size by Application (2027-2032) & (US$ Million) Table 173. Asia Tumor Target Capture Platform Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Asia Tumor Target Capture Platform Market Size by Country (2021-2026) Table 175. Asia Tumor Target Capture Platform Market Size by Country (2027-2032) Table 176. South America, Middle East & Africa Tumor Target Capture Platform Market Size by Type (2021-2026) & (US$ Million) Table 177. South America, Middle East & Africa Tumor Target Capture Platform Market Size by Type (2027-2032) & (US$ Million) Table 178. South America, Middle East & Africa Tumor Target Capture Platform Market Size by Application (2021-2026) & (US$ Million) Table 179. South America, Middle East & Africa Tumor Target Capture Platform Market Size by Application (2027-2032) & (US$ Million) Table 180. South America, Middle East & Africa Tumor Target Capture Platform Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. South America, Middle East & Africa Tumor Target Capture Platform Market Size by Country (2021-2026) Table 182. South America, Middle East & Africa Tumor Target Capture Platform Market Size by Country (2027-2032) Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources Table 186. Primary Sources List of Figures Figure 1. Tumor Target Capture Platform Product Image Figure 2. Global Tumor Target Capture Platform Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Tumor Target Capture Platform Market Share by Type: 2025 VS 2032 Figure 4. Immunoaffinity Capture Platform Image Figure 5. Aptamer Capture Platform Image Figure 6. Physical Separation Platform Image Figure 7. Global Tumor Target Capture Platform Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Tumor Target Capture Platform Market Share by Application: 2025 VS 2032 Figure 9. Clinical Diagnostics Industry Image Figure 10. Laboratory Industry Image Figure 11. Research and Higher Education Industry Image Figure 12. Others Image Figure 13. Global Tumor Target Capture Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 15. Global Tumor Target Capture Platform Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Tumor Target Capture Platform Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Tumor Target Capture Platform Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Tumor Target Capture Platform Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Tumor Target Capture Platform Revenue Market Share by Type (2021-2032) Figure 22. Global Tumor Target Capture Platform Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Tumor Target Capture Platform Revenue Market Share by Application (2021-2032) Figure 24. North America Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 25. North America Tumor Target Capture Platform Market Share by Type (2021-2032) Figure 26. North America Tumor Target Capture Platform Market Share by Application (2021-2032) Figure 27. North America Tumor Target Capture Platform Market Share by Country (2021-2032) Figure 28. United States Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 29. Canada Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 31. Europe Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 32. Europe Tumor Target Capture Platform Market Share by Type (2021-2032) Figure 33. Europe Tumor Target Capture Platform Market Share by Application (2021-2032) Figure 34. Europe Tumor Target Capture Platform Market Share by Country (2021-2032) Figure 35. Germany Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 36. France Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 38. Italy Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 39. Russia Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 41. China Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 42. China Tumor Target Capture Platform Market Share by Type (2021-2032) Figure 43. China Tumor Target Capture Platform Market Share by Application (2021-2032) Figure 44. Asia Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 45. Asia Tumor Target Capture Platform Market Share by Type (2021-2032) Figure 46. Asia Tumor Target Capture Platform Market Share by Application (2021-2032) Figure 47. Asia Tumor Target Capture Platform Market Share by Country (2021-2032) Figure 48. Japan Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 52. India Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 53. Australia Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Tumor Target Capture Platform Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Tumor Target Capture Platform Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Tumor Target Capture Platform Market Share by Country (2021-2032) Figure 58. Brazil Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 63. UAE Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 65. Chile Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Immunoaffinity Capture Platform
  • Aptamer Capture Platform
  • Physical Separation Platform
Applications
  • Clinical Diagnostics Industry
  • Laboratory Industry
  • Research and Higher Education Industry
  • Others
Companies covered
  • Roche
  • Guardant Health
  • Illumina
  • Bio-Rad
  • Menarini Silicon Biosystems
  • GRAIL
  • Freenome
  • Angle
  • Exosome Diagnostics
  • Nanostring
  • Cell Microsystems
  • Vortex Biosciences
  • MagArray
  • Qiagen
  • Adaptive Biotechnologies
  • Mission Bio
  • Singleron
  • BGI
  • Amoy Diagnostics
  • GenoSaber
  • Annoroad
  • Genecast
  • Precision Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Tumor Target Capture Platform Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Immunoaffinity Capture Platform
  5. 1.2.3 Aptamer Capture Platform
  6. 1.2.4 Physical Separation Platform
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Tumor Target Capture Platform Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Clinical Diagnostics Industry
  10. 1.3.3 Laboratory Industry
  11. 1.3.4 Research and Higher Education Industry
  12. 1.3.5 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Tumor Target Capture Platform Growth Trends by Region
  15. 1.5.1 Global Tumor Target Capture Platform Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Tumor Target Capture Platform Market Size by Region (2021-2026)
  17. 1.5.3 Tumor Target Capture Platform Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Tumor Target Capture Platform Market Dynamics
  1. 2.1 Tumor Target Capture Platform Industry Trends
  2. 2.2 Tumor Target Capture Platform Industry Drivers
  3. 2.3 Tumor Target Capture Platform Industry Opportunities and Challenges
  4. 2.4 Tumor Target Capture Platform Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Tumor Target Capture Platform Revenue by Company (2021-2026)
  2. 3.2 Global Tumor Target Capture Platform Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Tumor Target Capture Platform Key Company Head office and Area Served
  4. 3.4 Global Tumor Target Capture Platform Company, Product Type & Application
  5. 3.5 Global Tumor Target Capture Platform Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Tumor Target Capture Platform Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Tumor Target Capture Platform Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Tumor Target Capture Platform Tier 1, Tier 2, and Tier 3
4 Tumor Target Capture Platform Market by Type
  1. 4.1 Global Tumor Target Capture Platform Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Tumor Target Capture Platform Market Size by Type (2021-2032)
  3. 4.3 Global Tumor Target Capture Platform Market Size Share by Type (2021-2032)
5 Tumor Target Capture Platform Market by Application
  1. 5.1 Global Tumor Target Capture Platform Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Tumor Target Capture Platform Market Size by Application (2021-2032)
  3. 5.3 Global Tumor Target Capture Platform Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Roche Tumor Target Capture Platform Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Guardant Health
  8. 6.2.1 Guardant Health Company Information
  9. 6.2.2 Guardant Health Business Overview
  10. 6.2.3 Guardant Health Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Guardant Health Tumor Target Capture Platform Product Portfolio
  12. 6.2.5 Guardant Health Recent Developments
  13. 6.3 Illumina
  14. 6.3.1 Illumina Company Information
  15. 6.3.2 Illumina Business Overview
  16. 6.3.3 Illumina Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Illumina Tumor Target Capture Platform Product Portfolio
  18. 6.3.5 Illumina Recent Developments
  19. 6.4 Bio-Rad
  20. 6.4.1 Bio-Rad Company Information
  21. 6.4.2 Bio-Rad Business Overview
  22. 6.4.3 Bio-Rad Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Bio-Rad Tumor Target Capture Platform Product Portfolio
  24. 6.4.5 Bio-Rad Recent Developments
  25. 6.5 Menarini Silicon Biosystems
  26. 6.5.1 Menarini Silicon Biosystems Company Information
  27. 6.5.2 Menarini Silicon Biosystems Business Overview
  28. 6.5.3 Menarini Silicon Biosystems Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Menarini Silicon Biosystems Tumor Target Capture Platform Product Portfolio
  30. 6.5.5 Menarini Silicon Biosystems Recent Developments
  31. 6.6 GRAIL
  32. 6.6.1 GRAIL Company Information
  33. 6.6.2 GRAIL Business Overview
  34. 6.6.3 GRAIL Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 GRAIL Tumor Target Capture Platform Product Portfolio
  36. 6.6.5 GRAIL Recent Developments
  37. 6.7 Freenome
  38. 6.7.1 Freenome Company Information
  39. 6.7.2 Freenome Business Overview
  40. 6.7.3 Freenome Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Freenome Tumor Target Capture Platform Product Portfolio
  42. 6.7.5 Freenome Recent Developments
  43. 6.8 Angle
  44. 6.8.1 Angle Company Information
  45. 6.8.2 Angle Business Overview
  46. 6.8.3 Angle Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Angle Tumor Target Capture Platform Product Portfolio
  48. 6.8.5 Angle Recent Developments
  49. 6.9 Exosome Diagnostics
  50. 6.9.1 Exosome Diagnostics Company Information
  51. 6.9.2 Exosome Diagnostics Business Overview
  52. 6.9.3 Exosome Diagnostics Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Exosome Diagnostics Tumor Target Capture Platform Product Portfolio
  54. 6.9.5 Exosome Diagnostics Recent Developments
  55. 6.10 Nanostring
  56. 6.10.1 Nanostring Company Information
  57. 6.10.2 Nanostring Business Overview
  58. 6.10.3 Nanostring Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Nanostring Tumor Target Capture Platform Product Portfolio
  60. 6.10.5 Nanostring Recent Developments
  61. 6.11 Cell Microsystems
  62. 6.11.1 Cell Microsystems Company Information
  63. 6.11.2 Cell Microsystems Business Overview
  64. 6.11.3 Cell Microsystems Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Cell Microsystems Tumor Target Capture Platform Product Portfolio
  66. 6.11.5 Cell Microsystems Recent Developments
  67. 6.12 Vortex Biosciences
  68. 6.12.1 Vortex Biosciences Company Information
  69. 6.12.2 Vortex Biosciences Business Overview
  70. 6.12.3 Vortex Biosciences Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Vortex Biosciences Tumor Target Capture Platform Product Portfolio
  72. 6.12.5 Vortex Biosciences Recent Developments
  73. 6.13 MagArray
  74. 6.13.1 MagArray Company Information
  75. 6.13.2 MagArray Business Overview
  76. 6.13.3 MagArray Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 MagArray Tumor Target Capture Platform Product Portfolio
  78. 6.13.5 MagArray Recent Developments
  79. 6.14 Qiagen
  80. 6.14.1 Qiagen Company Information
  81. 6.14.2 Qiagen Business Overview
  82. 6.14.3 Qiagen Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Qiagen Tumor Target Capture Platform Product Portfolio
  84. 6.14.5 Qiagen Recent Developments
  85. 6.15 Adaptive Biotechnologies
  86. 6.15.1 Adaptive Biotechnologies Company Information
  87. 6.15.2 Adaptive Biotechnologies Business Overview
  88. 6.15.3 Adaptive Biotechnologies Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Adaptive Biotechnologies Tumor Target Capture Platform Product Portfolio
  90. 6.15.5 Adaptive Biotechnologies Recent Developments
  91. 6.16 Mission Bio
  92. 6.16.1 Mission Bio Company Information
  93. 6.16.2 Mission Bio Business Overview
  94. 6.16.3 Mission Bio Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Mission Bio Tumor Target Capture Platform Product Portfolio
  96. 6.16.5 Mission Bio Recent Developments
  97. 6.17 Singleron
  98. 6.17.1 Singleron Company Information
  99. 6.17.2 Singleron Business Overview
  100. 6.17.3 Singleron Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Singleron Tumor Target Capture Platform Product Portfolio
  102. 6.17.5 Singleron Recent Developments
  103. 6.18 BGI
  104. 6.18.1 BGI Company Information
  105. 6.18.2 BGI Business Overview
  106. 6.18.3 BGI Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 BGI Tumor Target Capture Platform Product Portfolio
  108. 6.18.5 BGI Recent Developments
  109. 6.19 Amoy Diagnostics
  110. 6.19.1 Amoy Diagnostics Company Information
  111. 6.19.2 Amoy Diagnostics Business Overview
  112. 6.19.3 Amoy Diagnostics Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Amoy Diagnostics Tumor Target Capture Platform Product Portfolio
  114. 6.19.5 Amoy Diagnostics Recent Developments
  115. 6.20 GenoSaber
  116. 6.20.1 GenoSaber Company Information
  117. 6.20.2 GenoSaber Business Overview
  118. 6.20.3 GenoSaber Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 GenoSaber Tumor Target Capture Platform Product Portfolio
  120. 6.20.5 GenoSaber Recent Developments
  121. 6.21 Annoroad
  122. 6.21.1 Annoroad Company Information
  123. 6.21.2 Annoroad Business Overview
  124. 6.21.3 Annoroad Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Annoroad Tumor Target Capture Platform Product Portfolio
  126. 6.21.5 Annoroad Recent Developments
  127. 6.22 Genecast
  128. 6.22.1 Genecast Company Information
  129. 6.22.2 Genecast Business Overview
  130. 6.22.3 Genecast Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 Genecast Tumor Target Capture Platform Product Portfolio
  132. 6.22.5 Genecast Recent Developments
  133. 6.23 Precision Scientific
  134. 6.23.1 Precision Scientific Company Information
  135. 6.23.2 Precision Scientific Business Overview
  136. 6.23.3 Precision Scientific Tumor Target Capture Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 Precision Scientific Tumor Target Capture Platform Product Portfolio
  138. 6.23.5 Precision Scientific Recent Developments
7 North America
  1. 7.1 North America Tumor Target Capture Platform Market Size (2021-2032)
  2. 7.2 North America Tumor Target Capture Platform Market Size by Type
  3. 7.2.1 North America Tumor Target Capture Platform Market Size by Type (2021-2026)
  4. 7.2.2 North America Tumor Target Capture Platform Market Size by Type (2027-2032)
  5. 7.2.3 North America Tumor Target Capture Platform Market Share by Type (2021-2032)
  6. 7.3 North America Tumor Target Capture Platform Market Size by Application
  7. 7.3.1 North America Tumor Target Capture Platform Market Size by Application (2021-2026)
  8. 7.3.2 North America Tumor Target Capture Platform Market Size by Application (2027-2032)
  9. 7.3.3 North America Tumor Target Capture Platform Market Share by Application (2021-2032)
  10. 7.4 North America Tumor Target Capture Platform Market Size by Country
  11. 7.4.1 North America Tumor Target Capture Platform Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Tumor Target Capture Platform Market Size by Country (2021-2026)
  13. 7.4.3 North America Tumor Target Capture Platform Market Size by Country (2027-2032)
  14. 7.4.4 North America Tumor Target Capture Platform Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Tumor Target Capture Platform Market Size (2021-2032)
  2. 8.2 Europe Tumor Target Capture Platform Market Size by Type
  3. 8.2.1 Europe Tumor Target Capture Platform Market Size by Type (2021-2026)
  4. 8.2.2 Europe Tumor Target Capture Platform Market Size by Type (2027-2032)
  5. 8.2.3 Europe Tumor Target Capture Platform Market Share by Type (2021-2032)
  6. 8.3 Europe Tumor Target Capture Platform Market Size by Application
  7. 8.3.1 Europe Tumor Target Capture Platform Market Size by Application (2021-2026)
  8. 8.3.2 Europe Tumor Target Capture Platform Market Size by Application (2027-2032)
  9. 8.3.3 Europe Tumor Target Capture Platform Market Share by Application (2021-2032)
  10. 8.4 Europe Tumor Target Capture Platform Market Size by Country
  11. 8.4.1 Europe Tumor Target Capture Platform Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Tumor Target Capture Platform Market Size by Country (2021-2026)
  13. 8.4.3 Europe Tumor Target Capture Platform Market Size by Country (2027-2032)
  14. 8.4.4 Europe Tumor Target Capture Platform Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Tumor Target Capture Platform Market Size (2021-2032)
  2. 9.2 China Tumor Target Capture Platform Market Size by Type
  3. 9.2.1 China Tumor Target Capture Platform Market Size by Type (2021-2026)
  4. 9.2.2 China Tumor Target Capture Platform Market Size by Type (2027-2032)
  5. 9.2.3 China Tumor Target Capture Platform Market Share by Type (2021-2032)
  6. 9.3 China Tumor Target Capture Platform Market Size by Application
  7. 9.3.1 China Tumor Target Capture Platform Market Size by Application (2021-2026)
  8. 9.3.2 China Tumor Target Capture Platform Market Size by Application (2027-2032)
  9. 9.3.3 China Tumor Target Capture Platform Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Tumor Target Capture Platform Market Size (2021-2032)
  2. 10.2 Asia Tumor Target Capture Platform Market Size by Type
  3. 10.2.1 Asia Tumor Target Capture Platform Market Size by Type (2021-2026)
  4. 10.2.2 Asia Tumor Target Capture Platform Market Size by Type (2027-2032)
  5. 10.2.3 Asia Tumor Target Capture Platform Market Share by Type (2021-2032)
  6. 10.3 Asia Tumor Target Capture Platform Market Size by Application
  7. 10.3.1 Asia Tumor Target Capture Platform Market Size by Application (2021-2026)
  8. 10.3.2 Asia Tumor Target Capture Platform Market Size by Application (2027-2032)
  9. 10.3.3 Asia Tumor Target Capture Platform Market Share by Application (2021-2032)
  10. 10.4 Asia Tumor Target Capture Platform Market Size by Country
  11. 10.4.1 Asia Tumor Target Capture Platform Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Tumor Target Capture Platform Market Size by Country (2021-2026)
  13. 10.4.3 Asia Tumor Target Capture Platform Market Size by Country (2027-2032)
  14. 10.4.4 Asia Tumor Target Capture Platform Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Tumor Target Capture Platform Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Tumor Target Capture Platform Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Tumor Target Capture Platform Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Tumor Target Capture Platform Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Tumor Target Capture Platform Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Tumor Target Capture Platform Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Tumor Target Capture Platform Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Tumor Target Capture Platform Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Tumor Target Capture Platform Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Tumor Target Capture Platform Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Tumor Target Capture Platform Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Tumor Target Capture Platform Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Tumor Target Capture Platform Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Tumor Target Capture Platform Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst